Adri Harding

Adri Harding has over 20 years of experience in the pharmaceutical and biotechnology industry. Adri currently serves as the Associate Director of Quality Assurance GMP at Travere Therapeutics since June 2022. Prior to this, they worked at Arena Pharmaceuticals as a Quality Assurance professional from August 2021 to June 2022. From July 2019 to August 2021, Adri was the Quality Assurance Manager at Neurocrine Biosciences, where they had previously held the position of Senior Quality Assurance Specialist from May 2016 to July 2019. Adri also worked as a Quality Assurance Consultant at Intercept Pharmaceuticals from December 2015 to March 2016. Before that, they served as a Senior Quality Assurance Specialist at Fate Therapeutics Inc from August 2014 to December 2015 and at Cubist Pharmaceuticals (formerly Trius Therapeutics) from March 2013 to July 2014. Adri began their career in the industry at Biogen Idec, where they worked as a Quality Assurance and Training professional from February 2002 to November 2005. Adri also has experience in Regulatory Affairs, having held roles at Verenium (now part of BASF), Vical, and Ceregene, Inc.

Adri Harding holds a Bachelor of Science (B.S.) degree from California Polytechnic State University-San Luis Obispo and a Master of Business Administration (M.B.A.) degree from National University.